Allergic rhinitis and sinusitis in asthma differential

Effects on symptoms and pulmonary function

Anne E. Dixon, David A. Kaminsky, Janet Teresa Holbrook, Robert A Wise, Dave Shade, Charles G. Irvin

Research output: Contribution to journalArticle

Abstract

Background: Allergic rhinitis and sinusitis are frequently associated with asthma. The purpose of this study was to determine the impact of self-reported allergic rhinitis and sinusitis on lower airway disease in a large cohort of participants with well-characterized asthma. Methods: A cohort study of participants in two trials of the American Lung Association-Asthma Clinical Research Centers: 2,031 asthmatics in the Safety of Inactivated Influenza Vaccine in Asthma in Adults and Children (SIIVA) trial and 488 asthmatics in the Effectiveness of Low Dose Theophylline as Add-on Treatment in Asthma (LODO) trial. At baseline, participants reported the presence of allergic rhinitis and sinusitis, and then lung function and asthma control were measured. During the trials, participants were monitored for asthma exacerbations. Results: More than 70% of participants reported either allergic rhinitis or sinusitis. Sinusitis was more common in female patients (odds ratio, 1.46 [SIIVA]), those with gastroesophageal reflux disease (odds ratio, 2.21 [SIIVA]), and those of white race (odds ratio, 1.53 [SIIVA]). Similar associations were seen for allergic rhinitis. LODO participants with allergic rhinitis and sinusitis had increased asthma symptoms and a trend toward more sleep disturbance. Participants with allergic rhinitis had higher baseline lung function than those without allergic rhinitis measured by peak flow (91.2% vs 95.8% in the SIIVA trial). Participants with sinusitis had similar lung function to those without sinusitis. Participants with and without allergic rhinitis had similar exacerbation rates. In the LODO trial only, participants with sinusitis had increased asthma exacerbations (5.68 per patient per year vs 3.72 per patient per year). Conclusion: Allergic rhinitis and sinusitis are associated with more severe asthmatic symptoms and, in patients with poorly controlled asthma, more exacerbations but are not associated with low lung function.

Original languageEnglish (US)
Pages (from-to)429-435
Number of pages7
JournalChest
Volume130
Issue number2
DOIs
StatePublished - Aug 2006

Fingerprint

Sinusitis
Asthma
Lung
Odds Ratio
Allergic Rhinitis
Inactivated Vaccines
Influenza Vaccines
Theophylline
Gastroesophageal Reflux
Sleep
Cohort Studies
Safety

Keywords

  • Allergic rhinitis
  • Asthma
  • Gastroesophageal reflux disease
  • Pulmonary function tests
  • Sinusitis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Allergic rhinitis and sinusitis in asthma differential : Effects on symptoms and pulmonary function. / Dixon, Anne E.; Kaminsky, David A.; Holbrook, Janet Teresa; Wise, Robert A; Shade, Dave; Irvin, Charles G.

In: Chest, Vol. 130, No. 2, 08.2006, p. 429-435.

Research output: Contribution to journalArticle

@article{54eab21fc83c46e9b7657c40fe4f77f8,
title = "Allergic rhinitis and sinusitis in asthma differential: Effects on symptoms and pulmonary function",
abstract = "Background: Allergic rhinitis and sinusitis are frequently associated with asthma. The purpose of this study was to determine the impact of self-reported allergic rhinitis and sinusitis on lower airway disease in a large cohort of participants with well-characterized asthma. Methods: A cohort study of participants in two trials of the American Lung Association-Asthma Clinical Research Centers: 2,031 asthmatics in the Safety of Inactivated Influenza Vaccine in Asthma in Adults and Children (SIIVA) trial and 488 asthmatics in the Effectiveness of Low Dose Theophylline as Add-on Treatment in Asthma (LODO) trial. At baseline, participants reported the presence of allergic rhinitis and sinusitis, and then lung function and asthma control were measured. During the trials, participants were monitored for asthma exacerbations. Results: More than 70{\%} of participants reported either allergic rhinitis or sinusitis. Sinusitis was more common in female patients (odds ratio, 1.46 [SIIVA]), those with gastroesophageal reflux disease (odds ratio, 2.21 [SIIVA]), and those of white race (odds ratio, 1.53 [SIIVA]). Similar associations were seen for allergic rhinitis. LODO participants with allergic rhinitis and sinusitis had increased asthma symptoms and a trend toward more sleep disturbance. Participants with allergic rhinitis had higher baseline lung function than those without allergic rhinitis measured by peak flow (91.2{\%} vs 95.8{\%} in the SIIVA trial). Participants with sinusitis had similar lung function to those without sinusitis. Participants with and without allergic rhinitis had similar exacerbation rates. In the LODO trial only, participants with sinusitis had increased asthma exacerbations (5.68 per patient per year vs 3.72 per patient per year). Conclusion: Allergic rhinitis and sinusitis are associated with more severe asthmatic symptoms and, in patients with poorly controlled asthma, more exacerbations but are not associated with low lung function.",
keywords = "Allergic rhinitis, Asthma, Gastroesophageal reflux disease, Pulmonary function tests, Sinusitis",
author = "Dixon, {Anne E.} and Kaminsky, {David A.} and Holbrook, {Janet Teresa} and Wise, {Robert A} and Dave Shade and Irvin, {Charles G.}",
year = "2006",
month = "8",
doi = "10.1378/chest.130.2.429",
language = "English (US)",
volume = "130",
pages = "429--435",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "2",

}

TY - JOUR

T1 - Allergic rhinitis and sinusitis in asthma differential

T2 - Effects on symptoms and pulmonary function

AU - Dixon, Anne E.

AU - Kaminsky, David A.

AU - Holbrook, Janet Teresa

AU - Wise, Robert A

AU - Shade, Dave

AU - Irvin, Charles G.

PY - 2006/8

Y1 - 2006/8

N2 - Background: Allergic rhinitis and sinusitis are frequently associated with asthma. The purpose of this study was to determine the impact of self-reported allergic rhinitis and sinusitis on lower airway disease in a large cohort of participants with well-characterized asthma. Methods: A cohort study of participants in two trials of the American Lung Association-Asthma Clinical Research Centers: 2,031 asthmatics in the Safety of Inactivated Influenza Vaccine in Asthma in Adults and Children (SIIVA) trial and 488 asthmatics in the Effectiveness of Low Dose Theophylline as Add-on Treatment in Asthma (LODO) trial. At baseline, participants reported the presence of allergic rhinitis and sinusitis, and then lung function and asthma control were measured. During the trials, participants were monitored for asthma exacerbations. Results: More than 70% of participants reported either allergic rhinitis or sinusitis. Sinusitis was more common in female patients (odds ratio, 1.46 [SIIVA]), those with gastroesophageal reflux disease (odds ratio, 2.21 [SIIVA]), and those of white race (odds ratio, 1.53 [SIIVA]). Similar associations were seen for allergic rhinitis. LODO participants with allergic rhinitis and sinusitis had increased asthma symptoms and a trend toward more sleep disturbance. Participants with allergic rhinitis had higher baseline lung function than those without allergic rhinitis measured by peak flow (91.2% vs 95.8% in the SIIVA trial). Participants with sinusitis had similar lung function to those without sinusitis. Participants with and without allergic rhinitis had similar exacerbation rates. In the LODO trial only, participants with sinusitis had increased asthma exacerbations (5.68 per patient per year vs 3.72 per patient per year). Conclusion: Allergic rhinitis and sinusitis are associated with more severe asthmatic symptoms and, in patients with poorly controlled asthma, more exacerbations but are not associated with low lung function.

AB - Background: Allergic rhinitis and sinusitis are frequently associated with asthma. The purpose of this study was to determine the impact of self-reported allergic rhinitis and sinusitis on lower airway disease in a large cohort of participants with well-characterized asthma. Methods: A cohort study of participants in two trials of the American Lung Association-Asthma Clinical Research Centers: 2,031 asthmatics in the Safety of Inactivated Influenza Vaccine in Asthma in Adults and Children (SIIVA) trial and 488 asthmatics in the Effectiveness of Low Dose Theophylline as Add-on Treatment in Asthma (LODO) trial. At baseline, participants reported the presence of allergic rhinitis and sinusitis, and then lung function and asthma control were measured. During the trials, participants were monitored for asthma exacerbations. Results: More than 70% of participants reported either allergic rhinitis or sinusitis. Sinusitis was more common in female patients (odds ratio, 1.46 [SIIVA]), those with gastroesophageal reflux disease (odds ratio, 2.21 [SIIVA]), and those of white race (odds ratio, 1.53 [SIIVA]). Similar associations were seen for allergic rhinitis. LODO participants with allergic rhinitis and sinusitis had increased asthma symptoms and a trend toward more sleep disturbance. Participants with allergic rhinitis had higher baseline lung function than those without allergic rhinitis measured by peak flow (91.2% vs 95.8% in the SIIVA trial). Participants with sinusitis had similar lung function to those without sinusitis. Participants with and without allergic rhinitis had similar exacerbation rates. In the LODO trial only, participants with sinusitis had increased asthma exacerbations (5.68 per patient per year vs 3.72 per patient per year). Conclusion: Allergic rhinitis and sinusitis are associated with more severe asthmatic symptoms and, in patients with poorly controlled asthma, more exacerbations but are not associated with low lung function.

KW - Allergic rhinitis

KW - Asthma

KW - Gastroesophageal reflux disease

KW - Pulmonary function tests

KW - Sinusitis

UR - http://www.scopus.com/inward/record.url?scp=33747613349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747613349&partnerID=8YFLogxK

U2 - 10.1378/chest.130.2.429

DO - 10.1378/chest.130.2.429

M3 - Article

VL - 130

SP - 429

EP - 435

JO - Chest

JF - Chest

SN - 0012-3692

IS - 2

ER -